ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 182 filers reported holding ASCENDIS PHARMA A/S in Q1 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,344,896 | -15.7% | 46,400 | -19.7% | 1.22% | -32.1% |
| Q2 2023 | $5,155,080 | +20.2% | 57,760 | +44.4% | 1.80% | +27.3% |
| Q1 2023 | $4,288,800 | -50.5% | 40,000 | -43.7% | 1.42% | -58.4% |
| Q4 2022 | $8,670,864 | -16.0% | 70,997 | -29.0% | 3.40% | +18.0% |
| Q3 2022 | $10,326,000 | -11.2% | 100,000 | -20.1% | 2.88% | -41.2% |
| Q2 2022 | $11,628,000 | -17.4% | 125,087 | +4.2% | 4.90% | +117.6% |
| Q1 2022 | $14,083,000 | +146.0% | 120,000 | +234.2% | 2.25% | +55.8% |
| Q3 2021 | $5,724,000 | +117.6% | 35,910 | +79.6% | 1.45% | +53.5% |
| Q2 2021 | $2,631,000 | -49.0% | 20,000 | -50.0% | 0.94% | -46.2% |
| Q1 2021 | $5,156,000 | +209.1% | 40,000 | +300.0% | 1.75% | +98.0% |
| Q4 2020 | $1,668,000 | – | 10,000 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |